TCTR20211203002尚未招募3 期
Efficacy of Vonoprazan, Sitafloxacin and Amoxicillin Regimen for Treatment of Refractory Helicobacter pylori infection
Routine to Research Unit, Siriraj Hospital0 个研究点目标入组 20 人开始时间: 2021年12月3日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Patient with refractory H.pylori defined as failed to at least 2 H.pylori eradication regimens
排除标准
- •- Patient with history to sitafloxacin, amoxycillin or vonoprazan allergy
- •- Pregnancy
- •- Patient with immunodeficiency, decompensated cirrhosis and end stage renal disease.
研究者
相似试验
尚未招募
4 期
Treatment regimen in Refractory Helicobacter pylori infectioPatients with refractory Helicobacter pylori infectionHelicobacter pyloriTreatment regimenTreatment failureTCTR20200910007Division of gastroenterology, Faculty of Medicine, Siriraj Hospital, Mahidol University20
招募中
2 期
VAS third-line eradication studyHelicobacter pylori infectionJPRN-jRCTs031190031Soichiro Sue68
Unknown
4 期
Efficacy of VAB (Vonoprazan, Amoxicillin and Bismuth subsalicylate) versus standard triple therapy for Helicobacter pyroli eradication: A randomized controlled trialHelicobacter pyroli eradication rate by VAB (Vonoprazan, Amoxicillin and Bismuth subsalicylate) regimenHelicobacter pyloriBismuth subsalicylateTCTR20210928005Department of Medicine, Phramongkutklao hospital160
招募中
不适用
Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori EradicatioH. pylori infectionJPRN-UMIN000022963Hamamatsu University School of Medicine100
已完成
2 期
The Efficacy of Metronidazole , Amoxicilin, Bismuth, Omeprazole – (OMAB) Based Quadruple Therapy for Eradication of Helicobacter Pylori Infection in Hamedanian PatientsPeptic ulcer disease.Peptic ulcer, Deudenal ulcer, GastritisK27.9, K26IRCT138901213676N1Hamedan university of medical sciences100